Is GeneReach Biotechnology stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, GeneReach Biotechnology pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Friday 28th of July 2023 were paid TWD1.5 per share. Over the last 3 times between 2021 and 2023, GeneReach Biotechnology has paid TWD8.07421 with an average of TWD2.69 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for GeneReach Biotechnology 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD36.03, you would have made a loss of TWD-7.23 per share or -20.07%
Yes, the average daily trading liquidity for GeneReach Biotechnology is TWD94 900 thousand. You should therefore be able to get in and out of your positions relatively fast.
GeneReach Biotechnology has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for GeneReach Biotechnology to be high [0.85 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.